Ana Maria Sandri

Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens

Ana Maria Sandri, Cornelia B. Landersdorfer, Jovan Jacob et al. · Clinical Infectious Diseases · 2013 · 428 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Reduction in Inddence of Nosocomial Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA) Infection in an Intensive Care Unit: Role of Treatment With Mupirocin Ointment and Chlorhexidine Baths for Nasal Carriers of MRSA

Ana Maria Sandri, Micheline Gisele Dalarosa, Luciana Ruschel de Alcântara et al. · Infection Control and Hospital Epidemiology · 2006 · 108 citations

Life Sciences, Infectious Diseases, Microbiology +17

Pharmacokinetics of polymyxin B in patients on continuous venovenous haemodialysis

Ana Maria Sandri, Cornelia B. Landersdorfer, Jovan Jacob et al. · Journal of Antimicrobial Chemotherapy · 2012 · 74 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Outbreak of Carbapenem-Resistant <i>Providencia stuartii</i> in an Intensive Care Unit

Alexandre Prehn Zavascki, Cecília G Carvalhaes, Geórgia L. da Silva et al. · Infection Control and Hospital Epidemiology · 2012 · 39 citations

Life Sciences, Infectious Diseases, Microbiology +17

Assessing the predictive performance of population pharmacokinetic models for intravenous polymyxin B in critically ill patients

Patrick O. Hanafin, Roger L. Nation, Marc H. Scheetz et al. · CPT Pharmacometrics & Systems Pharmacology · 2021 · 33 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17